drugset / Trial / NCT01709760
A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
RandomizedParallel-groupDouble-blindTreatment
Summary
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination with Methotrexate versus Methotrexate Alone in Patients with Rheumatoid Arthritis
Timeline
- Start
- 2012-11
- Primary completion
- 2017-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 25 mg | Subcutaneous |
| Background | Methotrexate | Small molecule | 15 mg | — |
| Background | Methotrexate | Small molecule | 25 mg | — |